CYP 17 and estrogen receptor α gene polymorphisms: association with breast cancer susceptibility and clinicopathological parameters in a cohort of Egyptian patients

2013 ◽  
Vol 23 (5) ◽  
pp. 1609-1617
Author(s):  
Nadida Gohar ◽  
Dina El Gayar ◽  
Marianne Samir M. Issac ◽  
Mohammed Shehata ◽  
Yasmine Khater ◽  
...  
2006 ◽  
Vol 20 (1) ◽  
pp. 14-34 ◽  
Author(s):  
Yongxian Ma ◽  
Pragati Katiyar ◽  
Laundette P. Jones ◽  
Saijun Fan ◽  
Yiyu Zhang ◽  
...  

Abstract The progesterone receptor (PR) plays roles in normal mammary development and breast cancer formation, where it may exert both stimulatory and inhibitory actions. Previously, the breast cancer susceptibility gene product BRCA1 was found to interact with and inhibit the transcriptional activity of estrogen receptor-α. In this study, we found that exogenous wild-type BRCA1 inhibited the activity of the PR in transient transfection assays utilizing a mouse mammary tumor virus-Luc reporter. Wild-type BRCA1 inhibited the activity of endogenous PR in human breast cancer cells (T47D and MCF-7) and inhibited the activity of exogenous PR-A, PR-B, and [PR-A plus PR-B] isoforms. On the other hand, knockdown of endogenous BRCA1 using small interfering RNA enhanced the progesterone-stimulated activity of the PR by about 4-fold. We documented an in vivo association of the endogenous BRCA1 with PR isoforms A and B and a direct in vitro interaction between BRCA1 and PR, which was partially mapped. Whereas down-regulation of the coactivator p300 contributes to the BRCA1-mediated repression of estrogen receptor-α, this mechanism does not contribute to inhibition of PR activity, because exogenous p300 did not rescue the BRCA1 repression of PR activity. The BRCA1-PR interaction has functional consequences. Thus, we showed that BRCA1 inhibits the expression of various endogenous progesterone-responsive genes and inhibits progesterone-stimulated proliferation of T47D cells. Finally, exogenous progesterone caused an exaggerated proliferative response in the mammary glands of mice harboring a mammary-targeted conditional deletion of the full-length isoform of Brca1. These findings suggest that BRCA1 regulates the activity of progesterone, a major hormone of pregnancy that may also participate in mammary carcinogenesis.


2004 ◽  
Vol 74 (6) ◽  
pp. 495-500 ◽  
Author(s):  
A. M. Boot ◽  
I. M. van der Sluis ◽  
S. M. P. F. de Muinck Keizer-Schrama ◽  
J. B. J. van Meurs ◽  
E. P. Krenning ◽  
...  

2014 ◽  
Vol 53 (7) ◽  
pp. e363-e364 ◽  
Author(s):  
Lyubomir Dourmishev ◽  
Zornitsa Kamenarska ◽  
Radka Kaneva ◽  
Vanio Mitev ◽  
Maria Hristova ◽  
...  

2012 ◽  
Vol 525 (1) ◽  
pp. 17-22 ◽  
Author(s):  
Benjamin B. Lahey ◽  
Kalina J. Michalska ◽  
Chunyu Liu ◽  
Qi Chen ◽  
Alison E. Hipwell ◽  
...  

2006 ◽  
Vol 1089 (1) ◽  
pp. 104-109 ◽  
Author(s):  
L. SCOLA ◽  
M. VAGLICA ◽  
A. CRIVELLO ◽  
L. PALMERI ◽  
G. I. FORTE ◽  
...  

2005 ◽  
Vol 16 (10) ◽  
pp. 1195-1202 ◽  
Author(s):  
N. Charlotte Onland-Moret ◽  
Carla H. van Gils ◽  
Mark Roest ◽  
Diederick E. Grobbee ◽  
Petra H. M. Peeters

2000 ◽  
Vol 57 (2) ◽  
pp. 236 ◽  
Author(s):  
Hirofumi Maruyama ◽  
Hiromasa Toji ◽  
Charles R. Harrington ◽  
Ken Sasaki ◽  
Yuishin Izumi ◽  
...  

2008 ◽  
Vol 63 (7) ◽  
pp. 435-436
Author(s):  
Karla L. Bretherick ◽  
Courtney W. Hanna ◽  
Lauren M. Currie ◽  
Margo R. Fluker ◽  
Geoffrey L. Hammond ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document